Quick Facts 2013
In Fiscal Year 2012, more than 115,000 people — nearly one-third of them new patients — sought the high-quality care that has made MD Anderson so widely respected. There were about 8,500 registrants on clinical trials exploring novel treatments, the largest such program in the nation.
|Clinical Activity||FY08||FY12||% Change|
|Hospital patient days||167,451||191,735||15%|
|Average number of hospital beds||510||616||21%|
|Outpatient clinic visits, treatments, procedures||965,248||1,281,489||33%|
|Pathology/laboratory medicine procedures||9,221,298||11,619,591||26%|
|Diagnostic imaging procedures||479,476||497,660||4%|
|Total active clinical research protocols||1,108||1,078||-3%|
- MD Anderson is accredited by the Joint Commission, an organization that ensures patients receive the best and safest health care possible.
- The nursing program holds Magnet Nursing Services Recognition status from the American Nurses Credentialing Center.
- For ten of the past 12 years, including 2013, MD Anderson has ranked No. 1 in cancer care in the “Best Hospitals” survey published by U.S. News & World Report.
- MD Anderson provided $212 million in uncompensated care to Texans with cancer in FY12. This figure includes unreimbursed costs of care for patients who either have no insurance or are underinsured, or whose care was not fully covered by government-sponsored health programs. It does not reflect a one-time $53 million refund, which was the result of a Medicare settlement to
MD Anderson for prior years and was recorded as a lump sum in the FY12 financial report.
- The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Care Therapy is an international center of clinical excellence focusing on using the latest advances in genetic testing to develop safer, more effective treatments for patients on a case-by-case basis.
At MD Anderson, important scientific knowledge gained in the laboratory is rapidly translated into clinical care. The research program is considered one of the most productive in the world aimed solely at cancer.
|Sources of Research Expenditures||FY08||FY12||% Change|
|Federal grants and contracts||$194,889,144||$196,753,104||1%|
|Private industry grants and contracts||$40,625,360||$68,413,794||68%|
|Philanthropy and foundations||$73,518,196||$100,794,491||37%|
|State funding allocated for research||$23,093,889||$40,019,178||73%|
|Internal funding allocated for research||$156,528,238||$241,560,330||54%|
|Total research expenditures||$488,654,827||$647,540,897||33%|
- The new Moon Shots Program will dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.
- MD Anderson ranks first in number of grants awarded, including 12 Specialized Programs of Research Excellence (SPORE) grants, and total amount of grant dollars from the National Cancer Institute.
- The Institute for Applied Cancer Science identifies and validates new cancer targets, converts the scientific knowledge into new cancer drugs and advances the novel agents into innovative clinical trials.
Sources of Revenue
Of MD Anderson’s total revenue of $3.7 billion in FY12, only 4.6% was general revenue appropriated by the State of Texas. Note: dollar figures presented here are in millions.
Almost 7,500 trainees, including physicians, scientists, nurses and allied health professionals, took part in educational programs at MD Anderson in FY12. The institution awards bachelor’s degrees in eight allied health disciplines and, in collaboration with the UT Health Science Center at Houston, awards M.S. and Ph.D. degrees at the UT Graduate School of Biomedical Sciences.
In addition, thousands of health professionals participate in continuing education and distance-learning opportunities. MD Anderson also provides education programs for healthy individuals, those at risk of cancer, patients, survivors and caregivers.
|Education Profile||FY08||FY12||% Change|
|Clinical residents, fellows||1,043||1,187||14%|
|Observers, visitors, special programs||600||431||-28%|
|Student programs participants||830||1,317||59%|
|School of Health Professions students||139||316||127%|
- Accreditation by the Commission on Colleges of the Southern Association of Colleges and Schools affirms MD Anderson as a major teaching institution.
- The School of Health Professions is launching a master of science in diagnostic genetics program in 2013.
MD Anderson continues to set the standard in cancer prevention research and the translation of new knowledge into innovative, multidisciplinary care for patients, survivors and people at average or elevated risk for developing cancer.
The Division of Cancer Prevention and Population Sciences at MD Anderson is dedicated to eradicating cancer through pioneering research in the roles that biologic, genetic, environmental, behavioral and social factors play in cancer development and investigations of behavioral, surgical, medical and social interventions to prevent or reduce cancer risk.
Through the Duncan Family Institute for Cancer Prevention and Risk Assessment, the division is investing in promising new research directions and integrating basic research and clinical studies to accelerate their translation from the clinic to the community.
The Cancer Prevention Center provides cancer risk assessments, screening exams based on genetics, age and gender, and personalized risk-reduction strategies, including chemoprevention.
|Prevention Research Funding||FY08||FY12||% Change|
|Donor and designated funds||$4,575,216||$6,443,888||41%|
|Federal grants and contracts||$23,620,580||$25,705,364||9%|
- MD Anderson's new Department of Health Services Research is focused on studying health care costs, quality and access, and seeks ways to improve health care delivery, safety, availability and affordability.
- The institution's integrative health initiative expands evidence-based, patient-centered and research-driven clinical services in exercise, nutrition, psychosocial, complementary therapies and tobacco cessation for people at elevated risk for cancer, patients in treatment and cancer survivors.
MD Anderson employs more than 19,000 people, including more than 1,600 faculty. A volunteer work force of 1,248 contributed 192,152 hours of service in FY12, equal to 92 full-time employees. Together they work toward fulfilling MD Anderson’s mission of eliminating cancer as a major health threat.
- MD Anderson has been recognized as a top employer for its wellness programs, for workers 50 and older by the American Association of Retired Persons and for its employment practices for employees with disabilities.
In addition to MD Anderson’s main campus in the Texas Medical Center in Houston, four regional care centers in the greater Houston area (Bay Area, Katy, Sugar Land, The Woodlands) and two research campuses in Bastrop County, Texas, the institution has developed a network of national and international locations.
MD Anderson Cancer Network™
- Banner MD Anderson Cancer Center (Gilbert, Ariz.)
- MD Anderson Cancer Center Orlando (Orlando, Fla.)
- Nine health systems and hospitals in eight states
MD Anderson affiliates
- MD Anderson Cancer Center Madrid (Madrid, Spain)
- MD Anderson Radiation Treatment Center at Presbyterian Kaseman Hospital (Albuquerque, N.M.)
- MD Anderson Radiation Treatment Center at American Hospital (Istanbul, Turkey)
Updated January 2013
MD Anderson: Quick look
First patient: 1944 (about 900,000 patients treated overall)
Ranking: No. 1 in cancer care, America’s Best Hospitals, U.S. News and World Report (top-ranked 10 of past 12 years)
Average number of operating beds: 631
Research grants: No. 1 in grants awarded and total grant dollars, National Cancer Institute
Active clinical research protocols: 1,078 (about 8,500 patient registrants)